Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ACON Aclarion, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $2.52 -4.5% | $15.06 -2.0% |
| StockIQ Score | 49D+ Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 60C+ | 13F |
| Fundamental | 27F | 35F |
| Growth | 54C- | 50C- |
| Fair Value | 55C | 38F |
| News | 56C | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Aclarion (ACON) slightly outperforms Ascentage Pharma (AAPG) in growth (54 vs. 50) and valuation (55 vs. 38), indicating stronger expected expansion and pricing relative to earnings. However, AAPG has a marginally better fundamental score (35 vs. 27), suggesting slightly healthier core business metrics. Both carry a "WEAK" rating, but ACON’s technical score (19 vs. 18) is also slightly higher.